latest news stock values companies glp-1 obesity cardiometabolic

latest news stock values companies glp-1 obesity cardiometabolic Drug Market: the rapid growth of the diabetes and drugs market GLP-1 Prescriptions Quadruple Since 2021

Name: latest news stock values companies glp-1 obesity cardiometabolic Drug Market: the rapid growth of the diabetes and drugs market GLP-1 Prescriptions Quadruple Since 2021
Brand: actil.am
SKU: 41591657639
Price: 29.22 USD
Availability: InStock
Rating: 4.1944 (14 reviews)

SKU: 41591657639

4.2

USD29.22 USD76.22

Pay in 4 interest-free payments of $7.30 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 31 - Sep 5

Description

Licensed indication : The same active ingredient may be marketed under different brand names for diabetes versus obesity (e.g., Ozempic vs Wegovy for semaglutide), with different pricing structures